O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.98B
AUM Growth
-$187M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
122
New
Increased
Reduced
Closed

Top Buys

1
+$81.8M
2
+$51.6M
3
+$30.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$23.2M
5
JBIO
Jade Biosciences
JBIO
+$18.1M

Top Sells

1
+$97.6M
2
+$76.6M
3
+$56.9M
4
SWTX
SpringWorks Therapeutics
SWTX
+$41.9M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.5M

Sector Composition

1 Healthcare 99.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$334M 8.4%
2,718,735
2
$302M 7.6%
2,813,200
3
$263M 6.62%
337,600
4
$203M 5.12%
15,518,492
+496,771
5
$160M 4.02%
7,959,538
6
$158M 3.98%
291,000
7
$145M 3.64%
8,288,510
8
$142M 3.57%
359,200
9
$134M 3.36%
1,708,000
+176,000
10
$115M 2.88%
208,000
+1,300
11
$111M 2.8%
341,900
-4,200
12
$105M 2.64%
336,300
+135,100
13
$100M 2.52%
593,434
+46,434
14
$93.6M 2.35%
210,287
+50,387
15
$81.8M 2.06%
465,000
16
$81.1M 2.04%
+3,034,858
17
$74.9M 1.88%
1,415,020
18
$65.9M 1.66%
3,027,328
19
$64.3M 1.62%
3,704,959
20
$62.5M 1.57%
5,693,589
21
$55.1M 1.39%
438,540
-496,100
22
$53.3M 1.34%
433,400
-229,100
23
$51.5M 1.29%
1,812,886
24
$48.8M 1.23%
1,877,850
-594,144
25
$48.5M 1.22%
2,578,979
-863,874
1
2 3 4 5